Literature DB >> 26725093

Radiotherapy treatment of the salivary glands, sialorrhea, and non-invasive mechanical ventilation in amyotrophic lateral sclerosis: what are we doing?

Giancarlo Garuti1, Jessica Mandrioli2, Antonio M Esquinas3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26725093     DOI： 10.1007/s00415-015-8003-1

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  5 in total

Review 1.  End-of-life management in patients with amyotrophic lateral sclerosis.

Authors:  Sheelah Connolly; Miriam Galvin; Orla Hardiman
Journal:  Lancet Neurol       Date:  2015-02-27       Impact factor: 44.182

Review 2.  Systematic review of the effectiveness of botulinum toxin or radiotherapy for sialorrhea in patients with amyotrophic lateral sclerosis.

Authors:  Carol A Stone; Norma O'Leary
Journal:  J Pain Symptom Manage       Date:  2008-08-03       Impact factor: 3.612

3.  Radiotherapy treatment of sialorrhea in patients with amyotrophic lateral sclerosis requiring non-invasive ventilation.

Authors:  Maria del Mar Amador; Avi Assouline; Jésus Gonzalez-Bermejo; Pierre-François Pradat
Journal:  J Neurol       Date:  2015-07-15       Impact factor: 4.849

4.  Salivary glands radiotherapy to reduce sialorrhea in amyotrophic lateral sclerosis: dose and energy.

Authors:  N Bourry; N Guy; J-L Achard; P Verrelle; P Clavelou; M Lapeyre
Journal:  Cancer Radiother       Date:  2013-03-19       Impact factor: 1.018

Review 5.  A review of options for treating sialorrhea in amyotrophic lateral sclerosis.

Authors:  Paolo Banfi; Nicola Ticozzi; Agata Lax; Giulia Andrea Guidugli; Antonello Nicolini; Vincenzo Silani
Journal:  Respir Care       Date:  2014-09-16       Impact factor: 2.258
  5 in total
  1 in total

1.  Response to the Letter to the Editor: "Radiotherapy of salivary glands as treatment of sialorrhea in patients with amyotrophic lateral sclerosis requiring non-invasive ventilation: what are we doing?".

Authors:  Maria del Mar Amador; Avi Assouline; Jésus Gonzalez-Bermejo; Pierre-François Pradat
Journal:  J Neurol       Date:  2016-02-25       Impact factor: 4.849
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.